Literature DB >> 19137313

Does the echogenicity of focal liver lesions on baseline gray-scale ultrasound interfere with the diagnostic performance of contrast-enhanced ultrasound?

Guang-Jian Liu1, Hui-Xiong Xu, Xiao-Yan Xie, Zuo-Feng Xu, Yan-Ling Zheng, Jin-Yu Liang, Ming-De Lu, Fuminori Moriyasu.   

Abstract

The objective was to evaluate whether the echogenicity of focal liver lesions (FLLs) on baseline gray-scale ultrasound (US) interferes with the diagnostic performance of contrast-enhanced US (CEUS) for small FLLs. Three-hundred and eighty-eight patients were examined by real-time CEUS using a sulfur hexafluoride-filled microbubble contrast agent. The images of 114 hyperechoic lesions, 30 isoechoic lesions and 244 hypoechoic lesions were reviewed by two blinded independent readers. A five-point confidence level was used to discriminate malignant from benign lesions, and specific diagnoses were made. The diagnostic performances were evaluated by receiver-operating characteristic (ROC) analysis. The diagnostic performances of CEUS on hyperechoic lesions in terms of the areas (Az) under the ROC curve were 0.987 (reader 1) and 0.981 (reader 2), and were 0.987 (reader 1) and 0.984 (reader 2) for iso- and hypoechoic lesions, respectively. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 87.0-95.9%, 93.1-100%, 88.6-100%, 70.0-97.1% and 90.0-95.1%, respectively. The echogenicity of FLLs on baseline gray-scale US does not appear to interfere with the diagnostic ability of CEUS for small FLLs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19137313     DOI: 10.1007/s00330-008-1251-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  17 in total

Review 1.  Basic acoustic properties of microbubbles.

Authors:  Nico de Jong; Ayache Bouakaz; Peter Frinking
Journal:  Echocardiography       Date:  2002-04       Impact factor: 1.724

2.  Low mechanical index contrast-enhanced sonographic findings of pyogenic hepatic abscesses.

Authors:  Orlando Catalano; Fabio Sandomenico; Mauro Mattace Raso; Alfredo Siani
Journal:  AJR Am J Roentgenol       Date:  2004-02       Impact factor: 3.959

3.  Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.

Authors:  Emilio Quaia; Fabrizio Calliada; Michele Bertolotto; Sandro Rossi; Lorena Garioni; Laura Rosa; Roberto Pozzi-Mucelli
Journal:  Radiology       Date:  2004-08       Impact factor: 11.105

4.  Dysplastic nodules in liver cirrhosis: detection with triple phase helical dynamic CT.

Authors:  J H Lim; M J Kim; C K Park; S S Kang; W J Lee; H K Lim
Journal:  Br J Radiol       Date:  2004-11       Impact factor: 3.039

5.  Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience.

Authors:  Hui-Xiong Xu; Ming-De Lu; Guang-Jian Liu; Xiao-Yan Xie; Zuo-Feng Xu; Yan-Ling Zheng; Jin-Yu Liang
Journal:  J Ultrasound Med       Date:  2006-01       Impact factor: 2.153

6.  Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI.

Authors:  Stephanie R Wilson; Tae Kyoung Kim; Hyun-Jung Jang; Peter N Burns
Journal:  AJR Am J Roentgenol       Date:  2007-07       Impact factor: 3.959

7.  Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008.

Authors:  M Claudon; D Cosgrove; T Albrecht; L Bolondi; M Bosio; F Calliada; J-M Correas; K Darge; C Dietrich; M D'Onofrio; D H Evans; C Filice; L Greiner; K Jäger; N de Jong; E Leen; R Lencioni; D Lindsell; A Martegani; S Meairs; C Nolsøe; F Piscaglia; P Ricci; G Seidel; B Skjoldbye; L Solbiati; L Thorelius; F Tranquart; H P Weskott; T Whittingham
Journal:  Ultraschall Med       Date:  2008-02       Impact factor: 6.548

8.  Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions.

Authors:  Alexandra von Herbay; Christoph Vogt; Reinhard Willers; Dieter Häussinger
Journal:  J Ultrasound Med       Date:  2004-12       Impact factor: 2.153

9.  Small hepatocellular carcinomas in patients with liver cirrhosis: potentials and limitations of contrast-enhanced power Doppler sonography.

Authors:  N Gritzmann
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-08       Impact factor: 2.566

Review 10.  The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.

Authors:  Josep M Llovet; Josep Fuster; Jordi Bruix
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

View more
  6 in total

Review 1.  The current status of contrast-enhanced ultrasound in China.

Authors:  Hui-Xiong Xu; Ming-De Lu
Journal:  J Med Ultrason (2001)       Date:  2010-04-21       Impact factor: 1.314

Review 2.  Contrast-enhanced US for characterization of focal liver lesions: a comprehensive meta-analysis.

Authors:  Menglin Wu; Liang Li; Jiahui Wang; Yanyan Zhang; Qi Guo; Xue Li; Xuening Zhang
Journal:  Eur Radiol       Date:  2017-11-30       Impact factor: 5.315

3.  Contrast enhanced ultrasound of hepatocellular carcinoma.

Authors:  Kazushi Numata; Wen Luo; Manabu Morimoto; Masaaki Kondo; Yosuke Kunishi; Tomohiko Sasaki; Akito Nozaki; Katsuaki Tanaka
Journal:  World J Radiol       Date:  2010-02-28

4.  The real capabilities of contrast-enhanced ultrasound in the characterization of solid focal liver lesions.

Authors:  Emilio Quaia
Journal:  Eur Radiol       Date:  2010-11-24       Impact factor: 5.315

Review 5.  Advantages and Limitations of Focal Liver Lesion Assessment with Ultrasound Contrast Agents: Comments on the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines.

Authors:  Liliana Chiorean; Claudio Tana; Barbara Braden; Cosmin Caraiani; Zeno Sparchez; Xin-Wu Cui; Ulrich Baum; Christoph F Dietrich
Journal:  Med Princ Pract       Date:  2016-06-17       Impact factor: 1.927

Review 6.  Current role of ultrasound in the diagnosis of hepatocellular carcinoma.

Authors:  Hironori Tanaka
Journal:  J Med Ultrason (2001)       Date:  2020-03-13       Impact factor: 1.314

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.